Iron mobilization by succinylacetone methyl ester in rats. A model study for hereditary tyrosinemia and porphyrias characterized by 5-aminolevulinic acid overload

Free Radical Research

Volumn 32, Issue 4, 2000, Pages 343-353

  Rocha, Maria E Merlin ^a   Bandy, Brian ^a   Costa, Cristine A ^a   De Barros, Marcelo P ^a   Pinto, Adriana M P ^a   Bechara, Etelvino J H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

5 aminolevulinic acid; Ferritin; Iron; Oxidative stress; Porphyria; Succinylacetone

Indexed keywords

AMINOLEVULINIC ACID; CARBONYL DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; IRON; PORPHOBILINOGEN SYNTHASE; SUCCINIC ACID DERIVATIVE; SUCCINYLACETONE METHYL ESTER; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; BRAIN LEVEL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; IRON BLOOD LEVEL; IRON KINETICS; LIVER LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PORPHYRIA; RAT; TRANSFERRIN BLOOD LEVEL; TREATMENT OUTCOME; TYROSINEMIA;

ANIMALIA;

EID: 0034065245     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760000300341     Document Type: Article

References (50)

1. G.A. Mitchell, M.A. Lambert and R.M. Tanguay (1995) Hereditary tyrosinemia. In The Metabolic Basis of Inherited Diseases, C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle (Eds.), 7th edn., McGraw-Hill book Co., New York, pp. 1077-1106.
2. D. Phaneuf, M. Hadchouel, R.M. Tanguay, C. Bréchot and N. Ferry (1995) Correction of fumarylacetoacetate hydrolase deficiency (type I tyrosinemia) in cultured human fibroblasts by retroviral-mediated gene transfer. Biochemical Biophysical Research Communications, 208, 957-963.
3. L.A. Goldsmith and C. LaBerge (1989) Tyrosinemia and related disorders. In The Metabolic Basis of Inherited Disease, Vol. I, C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle (Eds.), McGraw-Hill, New York, pp. 547-562.
4. R. Berger, H. van Faassen and G.P.A. Smith (1983) Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia. Clinica Chimica Acta, 134, 129-141.
5. S.P. Ebert, R.A. Hess, B.C. Frykholm and D.P. Tschudy (1979) Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and δ-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells. Biochemical Biophysical Research Communications, 88, 1382-1390.
6. J.T. Hindmarsh (1986) The porphyrias: recent advances. Clinical Chemistry, 32, 1255-1263.
7. H.P. Monteiro, D.S.P. Abdalla, A. Faljoni-Alário and E.J.H. Bechara (1986) Generation of active oxygen species during coupled autoxidation of oxyhemoglobin and δ-aminolevulinic acid. Biochim. Biophys. Acta, 881, 100-106.
8. E.J.H. Bechara, M.H.G. Medeiros, H.P. Monteiro, M. Hermes-Lima, B. Pereira, M. Demasi, C.A. Costa, D.S.P. Abdalla, J. Onuki, C.M.A. Wendel and P. DiMascio (1993) A free radical hypothesis of lead poisoning and inborn porphyrias associated with 5-aminolevulinic acid overload. Química Nova, 16, 385-392.
9. S. Toyokuni (1996) Iron-induced carcinogenesis: the role of redox regulation. Free Radical Biology and Medicine, 20, 553-566.
10. E.J.H. Bechara, M.H.G. Medeiros, L.H. Catalani, C.H.L. Soares, H.P. Monteiro, D.S.P. Abdalla, M. Cristoff, M. Hermes-Lima, B. Pereira, M. Demasi, I.L. Nantes, C.A. Costa, M.E.M. Rocha, P. DiMascio, C.M.A. Wendel, J. Onuki, C.A.A. Penatti and A.P. Pinto (1995) Enolizable carbonyl and imino metabolites may act as endogenous sources of reactive oxygen species. Ciência e Cultura, 47, 346-357.
11. H. Carvalho, E.J.H. Bechara, R. Meneghini and M. Demasi (1997) The heme precursor δ-aminolevulinic acid induces activation of cytosolic iron regulatory protein 1. Biochemical Journal, 328, 827-832.
12. C.G. Fraga, J. Onuki, F. Lusesoli, E.J.H. Bechara and P. DiMascio (1994) 5-Aminolevulinic acid mediates the in vivo and in vitro formation of 8-hydroxy-2′-deoxyguanosine in DNA. Carcinogenesis, 15, 2241-2244.
13. K.M. Morehouse, S.N.J. Moreno and R.P. Mason (1987) The one-electron reduction of uroporphyrin I by hepatic microsomes. Archives of Biochemistry and Biophysics, 257, 276-284.
14. A.M.del C. Batlle (1993) Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. Journal of Photochemistry and Photobiology B.: Biology, 20, 5-22.
15. H. Puy, J.C. Deybach, A. Bogdan, J. Callebert, M. Baumgartner, P. Voisin, Y. Nordmann and Y. Touitou (1996) Increased δ-aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat. Journal of Clinical Investigation, 97, 104-110.
16. D.P. Tschudy, R.A. Hess and B.C. Frykholm (1981) Inhibition of δ-aminolevulinic acid dehydratase by 4,6-dioxoheptanoic acid. Journal of Biological Chemistry, 256, 9915-9923.
17. C.A. Costa, G.C. Trivelato, M. Demasi and E.J.H. Bechara (1997) Determination of 5-aminolevulinic acid in blood plasma, tissues and cell cultures by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B: Biomedical Science Applications, 695, 245-250.
18. P. Lindroth and K. Mopper (1979) High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde. Analytical Chemistry, 51, 1667-1674.
19. D.T. Dexter, A. Carayon, M. Vidailhet, M. Ruberg, F. Agid, Y. Agid, A.J. Lees, F.R. Wells, P. Jenner and C.D. Marsden (1990) Decreased ferritin levels in brain in Parkinson's disease. Journal of Neurochemistry, 55, 16-20.
20. J. Bralet, L. Schreiber and C. Bouvier (1992) Effects of acidosis and anoxia on iron delocalization from brain homogenates. Biochemical Pharmacology, 43, 979-983.
21. R.L. Levine, D. Garland, C.N. Oliver, A. Amici, I. Climent, A.G. Lenz, B.W. Ahn, S. Shaltiel and E.R. Stadtman (1990) Determination of carbonyl content in oxidatively modified protein. Methods in Enzymology, 186, 464-502.
22. C.G. Fraga, B.E. Leibovitz and A.L. Tappel (1988) Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radical Biology and Medicine, 4, 155-161.
23. L. Flohé and F. Ötting (1984) Superoxide dismutase assays. Methods in Enzymology, 105, 93-104.
24. D.J. Crapo, J.M. McCord and I. Fridovich (1978) Preparation and assay of superoxide dismutases. Methods in Enzymology, 53, 382-393.
25. O.H. Lowry, H.J. Rosebrough, A.C. Farr and R.J. Randal (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
26. M.L. Adams, I. Ostapiuk and J.A. Grasso (1989) The effects of inhibition of heme synthesis on the intracellular localization of iron in rat reticulocytes. Biochimica Biophysica Acta, 1012, 243-253.
27. P.I. Oteiza, C.G. Kleinman, M. Demasi and E.J.H. Bechara (1995) 5-Aminolevulinic acid induces iron release from ferritin. Archives of Biochemistry and Biophysics, 316, 607-611.
28. G. Cairo, L. Tacchini, G. Pogliagihi, E. Anzon, A. Tomasi and A. Bernelli-Zazzera (1995) Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. Journal of Biological Chemistry, 270, 700-703.
29. M. Demasi, C.A. Penatti, R. DeLucia and E.J.H. Bechara (1996) The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatrie manifestations in porphyrias. Free Radical Biology and Medicine, 20, 291-299.
30. B. Pereira, R. Curi, E. Kokubun and E.J.H. Bechara (1992) 5-Aminolevulinic acid-induced alterations of oxidative metabolism in sedentary and exercise-trained rats. Journal of Applied Physiology, 72, 226-230.
31. M. Demasi, C.A. Costa, C. Pascual, S. Llesuy and E.J.H. Bechara (1997) Oxidative tissue response promoted by 5-aminolevulinic acid promptly induces the increase of plasma antioxidant capacity. Free Radical Research, 26, 235-243.
32. 2+ ions. Biochimica Biophysica Acta, 1225, 259-263.
33. P.I. Oteiza and E.J.H. Bechara (1993) 5-Aminolevulinic acid induces lipid-peroxidation in cardiolipin-rich liposomes. Archives of Biochemistry and Biophysics, 305, 282-287.
34. 2+ and membrane protein thiols. Biochimica Biophysica Acta, 1188, 86-92.
35. R.S. Eisenstein, D. Garcia-Mayol, W. Pettingell and H.N. Munro (1991) Regulation of ferritin and heme oxygenase synthesis in rat fibroblast by different forms of iron. Proceedings of the National Academy of Sciences USA, 88, 688-692.
36. H.P. Monteiro, D.S.P. Abdalla, O. Augusto and E.J.H. Bechara (1989) Free radical generation during 5-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinopathies. Archives of Biochemistry and Biophysics, 271, 206-216.
37. M. Hermes-Lima, V.G.R. Valle, A.E. Vercesi and E.J.H. Bechara (1991) Damage to rat liver mitochondria promoted by δ-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning. Biochimica Biophysica Acta, 1056, 57-63.
38. M. Hermes-Lima, R.F. Castilho, G.R. Valderez, E.J.H. Bechara and A.E. Vercesi (1992) Calcium-dependent mitochondrial oxidative damage promoted by 5-aminolevulinic acid. Biochimica Biophysica Acta, 1180, 201-206.
39. 2+ uptake and mitochondrial permeabilization. Archives of Biochemistry and Biophysics, 335, 53-60.
40. 2+ and 5-aminolevulinic acid-derived oxyradicals promote injury to isolated mitochondria? Free Radical Biology and Medicine, 19, 381-390.
41. L. Biempica, N. Kosower, M.H. Ma, S. Goldfisher (1974) Cytochemical and ultrastructural studies of liver in acute intermittent porphyria and porphyria cutanea tarda. Arch. Pathol. 98, 336-343.
42. F. Lithner and L. Wetterberg (1984) Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Medica Scandanavia, 215, 271-274.
43. R. Kauppinen and P. Mustajoki (1988) Acute hepatic porphyria and hepatocellular carcinoma. British Journal of Cancer, 57, 117-120.
44. P.A. Wyss, S.B. Boynton, J. Chu, R.F. Spencer and K.S. Roth (1992) Physiological basis for an animal model of the renal Fanconi syndrome: use of succinylacetone in the rat. Clinical Science, 83, 81-87.
45. P.A. Wyss, S. Boynton, J. Chu and K.S. Roth (1993) Tissue distribution of succinylacetone in the rat in vivo: a possible basis for neurotoxicity in hereditary infantile tyrosinemia. Biochimica Biophysica Acta, 1182, 323-328.
46. R. Jorquera and R.M. Tanguay (1997) The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion. Biochemical and Biophysical Research Communications, 232, 42-48.
47. 14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway. Journal of Biological Chemistry, 272, 24 426-24 432.
48. K. Muta and S.B. Krantz (1995) Inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells. Journal of Cellular Physiology, 163, 38-50.
49. R.C.G. Carneiro and R.J. Reiter (1998) Melatonin protects against lipid peroxidation induced by δ-aminolevulinic acid in rat cerrebellum, cortex and hippocampus. Neuroscience, 82, 293-299.
50. N. Ercal, P. Treratphan, T.C. Hammond, R.H. Mathews, N.H. Grannemann and D.R. Spitz (1996) In vivo indices if oxidative stress in lead exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine. Free Radical Biology and Medicine, 21, 157-161.